The Bottom Line

Xeroderma pigmentosum (XP) is a rare inherited condition that prevents the body from repairing damage caused by ultraviolet (UV) light. Children with XP can develop severe sunburn from just minutes of sun exposure, and their lifetime risk of skin cancer is dramatically higher than that of the general population. Many develop multiple skin cancers before adulthood. Strict, comprehensive sun protection — indoors and outdoors — is the cornerstone of care. While XP has no cure, early diagnosis, rigorous sun avoidance, and frequent skin surveillance can significantly reduce cancer burden and improve quality of life.

What Is Xeroderma Pigmentosum?

Xeroderma pigmentosum (XP) is a rare genetic condition — it affects roughly 1 in 1 million people in the United States, though rates are higher in some populations (Japan, North Africa, Middle East). It is caused by mutations in one of seven genes (labeled XPA through XPG) that are responsible for a DNA repair process called nucleotide excision repair (NER).

Here's what that means in plain language: every time your skin is exposed to UV light from the sun (or artificial sources like tanning beds, fluorescent lights, and even some indoor lighting), it damages the DNA inside skin cells. In most people, the body quickly repairs this damage — cutting out the broken DNA and replacing it with correct genetic code. In XP, this repair system is broken. Damage accumulates with every exposure, leading to cell death, premature aging of the skin, and — most seriously — cancer.

XP is inherited as an autosomal recessive condition: both parents must carry a non-working copy of the gene (without being affected themselves), and a child with XP inherits a broken copy from each parent.

Signs and Symptoms: What Does XP Look Like?

XP typically becomes apparent in the first year or two of life, when a child first has significant sun exposure:

  • Severe sunburn from tiny amounts of UV exposure: Minutes in the sun — not hours — can cause blistering, deep redness, and pain. This is often the first alarming sign that leads to diagnosis.
  • Freckling in sun-exposed areas: Dense, dark freckles appear on the face, hands, and other sun-exposed areas, even in very young children — far more than would be expected.
  • Poikiloderma: A mixture of skin changes — dark spots, light spots, small broken blood vessels — giving the skin a mottled, aged appearance in sun-exposed areas.
  • Photophobia: Extreme light sensitivity of the eyes, with painful inflammation of the cornea (keratitis). Many children with XP also develop cataracts and other eye complications.
  • Dry, parchment-like skin on sun-exposed areas — the name "xeroderma pigmentosum" literally means "dry pigmented skin."
  • Skin cancers: Many children with XP develop their first skin cancer before age 10. Some develop hundreds of skin cancers by adulthood. Basal cell carcinoma, squamous cell carcinoma, and melanoma are all dramatically more frequent.

Neurological Complications: Does XP Affect the Brain?

About 20–30% of XP patients develop progressive neurological problems. This is most common in people with XPA, XPB, XPD, and XPG mutations. Neurological symptoms may include:

  • Progressive hearing loss
  • Decline in coordination (ataxia)
  • Cognitive changes or learning difficulties
  • Loss of reflexes
  • In severe cases, wheelchair dependence

The exact cause of nerve damage in XP isn't fully understood, but it appears to involve accumulation of DNA damage in neurons — cells that don't regenerate. The presence of neurological features significantly affects long-term quality of life and is a sobering aspect of the more severe forms of XP.

How Is XP Diagnosed?

XP can be suspected when a child shows extreme photosensitivity, early-onset freckling, or multiple skin cancers at a very young age. Diagnosis is confirmed by:

  • DNA repair capacity testing: Specialized lab testing using cells from the patient to measure how well they repair UV-induced damage compared to normal cells
  • Genetic testing: Identifying the specific gene mutation (XPA through XPG) — this also helps predict the risk of neurological complications and guides counseling
  • Prenatal diagnosis: Available through fetal genetic testing for families with a known XP mutation

XP is often diagnosed late — sometimes only after a child develops a skin cancer. Raising awareness of the condition can help doctors recognize it earlier and initiate protection sooner.

Daily Life with XP: Sun Protection as Medical Treatment

For children with XP, sun protection is not optional — it is the primary medical intervention that prevents cancer and preserves vision. This requires a fundamental change to daily life:

Outdoors

  • Sun avoidance from sunrise to sunset, particularly on school days or when UV exposure is unavoidable
  • Protective clothing covering all skin: long sleeves, long pants, gloves, and UV-protective fabrics
  • Wide-brimmed hats and full face shields or UV-blocking face covers when outdoors
  • UV-protective sunglasses or goggles to protect the eyes
  • Broad-spectrum sunscreen (SPF 50+) on any exposed skin — multiple applications throughout the day
  • Tinted car windows with UV film; some families use UV-protective films on all home windows

Indoors

  • Regular fluorescent bulbs emit UV light — LED lighting or UV-filtering bulb covers are used in homes and classrooms
  • Windows at home and school should be covered with UV-blocking film
  • Many children with XP attend school after dark or through distance learning to avoid sun exposure entirely

Organizations like the Xeroderma Pigmentosum Society provide practical guidance for families navigating daily life with XP, including resources for school accommodations and equipment suppliers.

Medical Management and Skin Surveillance

Because skin cancer risk is so high, children with XP need very frequent dermatology check-ups — often every 3–6 months or more frequently depending on how many skin cancers have already appeared. At each visit:

  • The dermatologist performs a full skin exam to identify new or changing lesions
  • Suspicious spots are biopsied and treated promptly
  • Actinic keratoses (precancerous spots) are treated preventively
  • Oral retinoids (vitamin A derivatives) may be used to reduce new skin cancer formation in some patients
  • Research into DNA repair enhancement drugs is ongoing

Eye examinations by an ophthalmologist are equally important — ideally at the same frequency as skin checks.

When to See a Dermatologist

  • Your child develops severe sunburn from minimal sun exposure — minutes, not hours
  • Dense, early-onset freckling appears on a young child's face and sun-exposed areas
  • Any new or changing skin growth in a child known to have XP — do not wait for the next scheduled visit
  • Your family has a known XP mutation and you want guidance on surveillance and sun protection for a new child
  • You are seeking a second opinion on whether a child's sun sensitivity could be XP

Frequently Asked Questions

Can children with XP ever go outside?

Yes, with careful preparation. Some XP families schedule outdoor activities in the evening or early morning before sunrise, during winter months when UV is lower, or in locations where UV can be minimized (shaded areas, overcast days). Many children with XP do enjoy outdoor activities — it requires planning, protective clothing, and vigilance, but it is not impossible. Quality of life and social connection matter, and most XP specialists work with families to find safe ways to participate in activities.

What is the life expectancy for someone with XP?

With strict sun protection and rigorous skin surveillance, many people with XP live into adulthood. The presence or absence of neurological complications significantly affects prognosis. Historically, life expectancy was much shorter due to skin cancer burden; improved medical care and sun protection have improved outcomes. The XP type (which gene is affected) and access to specialized care are important factors.

Are there clinical trials or new treatments being studied?

Yes. Researchers are investigating ways to deliver functional DNA repair enzymes directly to the skin (using topical enzyme preparations or gene therapy approaches) and drugs that compensate for the missing repair pathway. T4N5 liposome lotion (a topical DNA repair enzyme) has been studied and showed reduction in skin cancer rates in a clinical trial. Families interested in clinical trials can inquire with a dermatologist who specializes in rare genetic skin conditions or through the XP Society.

Does XP affect only the skin?

No. XP can affect the eyes (causing severe photosensitivity, corneal damage, and cataracts), the nervous system (in 20–30% of patients), and raises the risk of some internal cancers (brain tumors, leukemia) — though skin and eye involvement are the most common concerns. Comprehensive care involves dermatology, ophthalmology, and neurology working together.

  1. Bradford PT, et al. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet. 2011;48(3):168–176.
  2. Lehmann AR, et al. Xeroderma pigmentosum. Orphanet J Rare Dis. 2011;6:70.
  3. Kraemer KH, et al. Xeroderma pigmentosum, trichothiodystrophy, and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience. 2007;145(4):1388–1396.
  4. Yarosh D, et al. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Lancet. 2001;357(9260):926–929.

Trusted Resources

Always consult a board-certified dermatologist specializing in rare genetic skin disorders for personalized guidance on xeroderma pigmentosum care and surveillance.